| Model Number |
FR995-25 |
| Medical Device Problem Codes |
Calcified (1077); Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Codes |
Calcium Deposits/Calcification (1758); Insufficient Information (4580)
|
| Date of Event |
01/20/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that 7 years and 1 month post implant of this 25mm aortic bioprosthetic valve, the patient is being evaluated for a transcatheter valve-in-valve replacement.The reason for evaluation was not reported.No intervention or adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
B1, b2, b5, h1 and h6 updated.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received that on january 27, 2026, the patient successfully had an aortic valve-in-valve replacement with a transcatheter valve.It was reported that an evaluation performed prior to the transcatheter valve being implanted noted calcium under the right coronary cusp (rcc), left coronary cusp (lcc), non-coronary cusp (ncc), ascending aorta and proximal left common carotid artery.The reason for intervention was not reported.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|